跳至主要内容
临床试验/NCT06344650
NCT06344650招募中不适用

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study

IRCCS San Raffaele1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Identify the rate of morphometric vertebral fractures in acromegalic patients

研究概览

简要总结

Prospective observational clinical, molecular, translational study aimed at identifying the main determinants and predictive factors of fragility fracture risck in acromegaly patients

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • confirmed diagnosis of acromegaly
  • availability to carry out outpatient checks
  • ability to provide informed consent

排除标准

  • Pregnancy
  • use of glucocorticoids (except those in use for replacement therapy)
  • alcohol abuse
  • exacerbation of chronic disease
  • serious comorbidities (renal or hepatic failure, heart attack, stroke)
  • terminally ill, prolonged immobilization (>1 week)
  • clinically evident fracture within the previous six months
  • any other cause of secondary osteoporosis within the last five years
  • any prolonged treatment with drugs with documented influence on bone metabolism during the previous 12 months, including treatment with antiresorptive or anabolic compounds for osteoporosis.

结局指标

主要结局

Identify the rate of morphometric vertebral fractures in acromegalic patients

时间窗: 18 months

Identify the rate of morphometric vertebral fractures in acromegalic patients 18 months after hospitalization for neurosurgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Giustina

Head of Endocrinology

IRCCS Ospedale San Raffaele

研究点 (1)

Loading locations...

相似试验